Northern Trust’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-764,310
| Closed | -$15.4M | – | 4808 |
|
|
2021
Q3 | $15.4M | Sell |
764,310
-11,349
| -1% | -$313K | ﹤0.01% | 1972 |
|
|
2021
Q2 | $28.9M | Buy |
775,659
+4,190
| +0.5% | +$128K | 0.01% | 1623 |
|
|
2021
Q1 | $19.7M | Sell |
771,469
-62,427
| -7% | -$1.59M | ﹤0.01% | 1833 |
|
|
2020
Q4 | $18.4M | Sell |
833,896
-15,966
| -2% | -$352K | ﹤0.01% | 1848 |
|
|
2020
Q3 | $15.3M | Sell |
849,862
-34,744
| -4% | -$719K | ﹤0.01% | 1823 |
|
|
2020
Q2 | $22.5M | Buy |
884,606
+165,013
| +23% | +$3.55M | 0.01% | 1517 |
|
|
2020
Q1 | $13.2M | Buy |
719,593
+32,342
| +5% | +$629K | ﹤0.01% | 1703 |
|
|
2019
Q4 | $15.1M | Sell |
687,251
-191
| -0% | -$3.84K | ﹤0.01% | 1919 |
|
|
2019
Q3 | $9.87M | Buy |
687,442
+3,760
| +0.5% | +$53.7K | ﹤0.01% | 2147 |
|
|
2019
Q2 | $10.8M | Buy |
683,682
+24,348
| +4% | +$331K | ﹤0.01% | 2106 |
|
|
2019
Q1 | $9.66M | Buy |
659,334
+12,191
| +2% | +$140K | ﹤0.01% | 2168 |
|
|
2018
Q4 | $6.92M | Buy |
647,143
+88,559
| +16% | +$1.16M | ﹤0.01% | 2307 |
|
|
2018
Q3 | $8.52M | Buy |
558,584
+71,916
| +15% | +$1.05M | ﹤0.01% | 2351 |
|
|
2018
Q2 | $5.96M | Buy |
486,668
+427,284
| +720% | +$5.37M | ﹤0.01% | 2595 |
|
|
2018
Q1 | $568K | Buy |
59,384
+23,102
| +64% | +$249K | ﹤0.01% | 3531 |
|
|
2017
Q4 | $327K | Buy |
36,282
+272
| +0.8% | +$2K | ﹤0.01% | 3663 |
|
|
2017
Q3 | $207K | Sell |
36,010
-209
| -0.6% | -$761 | ﹤0.01% | 3792 |
|
|
2017
Q2 | $114K | Buy |
36,219
+2,094
| +6% | +$6.61K | ﹤0.01% | 3945 |
|
|
2017
Q1 | $116K | Buy |
34,125
+1,274
| +4% | +$3.59K | ﹤0.01% | 3925 |
|
|
2016
Q4 | $94K | Sell |
32,851
-10,761
| -25% | -$38.2K | ﹤0.01% | 3916 |
|
|
2016
Q3 | $257K | Buy |
43,612
+7,149
| +20% | +$25.1K | ﹤0.01% | 3666 |
|
|
2016
Q2 | $109K | Sell |
36,463
-140,182
| -79% | -$576K | ﹤0.01% | 3871 |
|
|
2016
Q1 | $946K | Buy |
176,645
+6,177
| +4% | +$39K | ﹤0.01% | 3275 |
|
|
2015
Q4 | $2.02M | Sell |
170,468
-291
| -0.2% | -$3.33K | ﹤0.01% | 3060 |
|
|
2015
Q3 | $1.4M | Buy |
170,759
+97,779
| +134% | +$1.13M | ﹤0.01% | 3218 |
|
|
2015
Q2 | $1.02M | Buy |
72,980
+20,143
| +38% | +$369K | ﹤0.01% | 3335 |
|
|
2015
Q1 | $1.27M | Buy |
52,837
+4,332
| +9% | +$97.4K | ﹤0.01% | 3327 |
|
|
2014
Q4 | $799K | Buy |
48,505
+2,197
| +5% | +$25.4K | ﹤0.01% | 3446 |
|
|
2014
Q3 | $590K | Buy |
46,308
+4,618
| +11% | +$69.6K | ﹤0.01% | 3532 |
|
|
2014
Q2 | $941K | Buy |
41,690
+21,967
| +111% | +$398K | ﹤0.01% | 3416 |
|
|
2014
Q1 | $557K | Buy |
+19,723
| New | +$733K | ﹤0.01% | 3527 |
|
Other funds holding DRNA
Northern Trust's DRNA Position: Q4 2021 in Review
Northern Trust sold out of Dicerna Pharmaceuticals, Inc. (DRNA) in Q4 2021, closing a stake of 764,310 shares — an estimated $15.4M sold.
Northern Trust first reported a position in DRNA in Q1 2014 and held it in 31 quarters. The position peaked at $28.9M in Q2 2021. 1 fund tracked by Wall St. Rank holds DRNA as of Q4 2021.
- Northern Trust reported no remaining Dicerna Pharmaceuticals, Inc. position as of Q4 2021 after selling out during the quarter.
- Northern Trust sold 764,310 Dicerna Pharmaceuticals, Inc. shares in Q4 2021, an estimated $15.4M.
- Northern Trust first reported a position in Dicerna Pharmaceuticals, Inc. in Q1 2014 and held it in 31 quarters.
- Northern Trust's Dicerna Pharmaceuticals, Inc. position peaked at $28.9M in Q2 2021.
- 1 fund tracked by Wall St. Rank held Dicerna Pharmaceuticals, Inc. as of Q4 2021.
Based on Northern Trust's 13F filing for Q4 2021, filed 8 Feb 2022.